Literature DB >> 25986014

NK cells inhibit humoral immunity by reducing the abundance of CD4+ T follicular helper cells during a chronic virus infection.

Kevin D Cook1, Hannah C Kline1, Jason K Whitmire2.   

Abstract

There is a need to understand better how to improve B cell responses and immunity to persisting virus infections, which often cause debilitating illness or death. People with chronic virus infection show evidence of improved virus control when there is a strong neutralizing antibody response, and conversely, B cell dysfunction is associated with higher viral loads. We showed previously that NK cells inhibit CD4(+) and CD8(+) T cell responses to disseminating LCMV infection and that depletion of NK cells attenuates chronic infection. Here, we examined the effect of NK cell depletion on B cell responses to LCMV infection in mice. Whereas mice infected acutely generated a peak level of antibody soon after the infection was resolved, mice infected chronically showed a continued increase in antibody levels that exceeded those after acute infection. We found that early NK cell depletion rapidly increased virus-specific antibody levels to chronic infection, and this effect depended on CD4(+) T cells and was associated with elevated numbers of CXCR5(+)CD4(+) TFH cells. However, the NK cell-depleted mice controlled the infection and by 1 mo pi, had lower TFH cell numbers and antibody levels compared with mice with sustained infection. Finally, we show that NK cell depletion improved antiviral CD8(+) T cell responses only when B cells and virus-specific antibody were present. Our data indicate that NK cells diminish immunity to chronic infection, in part, by suppressing TFH cell and antibody responses. © Society for Leukocyte Biology.

Entities:  

Keywords:  antibody; host defense; immune regulation; lymphocytic choriomeningitis virus; mice

Mesh:

Substances:

Year:  2015        PMID: 25986014      PMCID: PMC4763952          DOI: 10.1189/jlb.4HI1214-594R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  72 in total

1.  Parameters governing exhaustion of rare T cell-independent neutralizing IgM-producing B cells after LCMV infection.

Authors:  Raphaël M Zellweger; Lars Hangartner; Jacqueline Weber; Rolf M Zinkernagel; Hans Hengartner
Journal:  Eur J Immunol       Date:  2006-12       Impact factor: 5.532

2.  Detection of intracellular cytokines by flow cytometry.

Authors:  Barbara Foster; Calman Prussin; Fei Liu; Jason K Whitmire; J Lindsay Whitton
Journal:  Curr Protoc Immunol       Date:  2007-08

3.  Interleukin-10 determines viral clearance or persistence in vivo.

Authors:  David G Brooks; Matthew J Trifilo; Kurt H Edelmann; Luc Teyton; Dorian B McGavern; Michael B A Oldstone
Journal:  Nat Med       Date:  2006-10-15       Impact factor: 53.440

4.  ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells.

Authors:  Lukas Bossaller; Jan Burger; Ruth Draeger; Bodo Grimbacher; Rolf Knoth; Alessandro Plebani; Anne Durandy; Ulrich Baumann; Michael Schlesier; Andrew A Welcher; Hans Hartmut Peter; Klaus Warnatz
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

5.  Type 1 IFN deficiency in the absence of normal splenic architecture during lymphocytic choriomeningitis virus infection.

Authors:  Jennifer Louten; Nico van Rooijen; Christine A Biron
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

Review 6.  Follicular B helper T cells in antibody responses and autoimmunity.

Authors:  Carola G Vinuesa; Stuart G Tangye; Bernhard Moser; Charles R Mackay
Journal:  Nat Rev Immunol       Date:  2005-11       Impact factor: 53.106

7.  Molecular signature of CD8+ T cell exhaustion during chronic viral infection.

Authors:  E John Wherry; Sang-Jun Ha; Susan M Kaech; W Nicholas Haining; Surojit Sarkar; Vandana Kalia; Shruti Subramaniam; Joseph N Blattman; Daniel L Barber; Rafi Ahmed
Journal:  Immunity       Date:  2007-10-18       Impact factor: 31.745

8.  B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation.

Authors:  S H Clarke; L W Arnold
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

9.  Resolution of a chronic viral infection after interleukin-10 receptor blockade.

Authors:  Mette Ejrnaes; Christophe M Filippi; Marianne M Martinic; Eleanor M Ling; Lisa M Togher; Shane Crotty; Matthias G von Herrath
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

10.  Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.

Authors:  Lars Hangartner; Raphaël M Zellweger; Mattia Giobbi; Jacqueline Weber; Bruno Eschli; Kathy D McCoy; Nicola Harris; Mike Recher; Rolf M Zinkernagel; Hans Hengartner
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307

View more
  30 in total

Review 1.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

Review 2.  NK cells in host responses to viral infections.

Authors:  Viola C Lam; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2016-12-13       Impact factor: 7.486

3.  Regulatory B Cell-Dependent Islet Transplant Tolerance Is Also Natural Killer Cell Dependent.

Authors:  C Schuetz; K M Lee; R Scott; L Kojima; L Washburn; L Liu; W-H Liu; H Tector; J Lei; H Yeh; J I Kim; J F Markmann
Journal:  Am J Transplant       Date:  2017-04-11       Impact factor: 8.086

Review 4.  Natural Killer Cell Regulation of B Cell Responses in the Context of Viral Infection.

Authors:  Ivayla E Gyurova; Ayad Ali; Stephen N Waggoner
Journal:  Viral Immunol       Date:  2019-12-03       Impact factor: 2.257

5.  Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment.

Authors:  Aliyah M Weinstein; Lu Chen; Emily A Brzana; Prashanti R Patil; Jennifer L Taylor; Kellsye L Fabian; Callen T Wallace; Sabrina D Jones; Simon C Watkins; Binfeng Lu; David F Stroncek; Timothy L Denning; Yang-Xin Fu; Peter A Cohen; Walter J Storkus
Journal:  Oncoimmunology       Date:  2017-04-28       Impact factor: 8.110

Review 6.  Viral subversion of B cell responses within secondary lymphoid organs.

Authors:  Mirela Kuka; Matteo Iannacone
Journal:  Nat Rev Immunol       Date:  2017-12-18       Impact factor: 53.106

7.  Weak vaccinia virus-induced NK cell regulation of CD4 T cells is associated with reduced NK cell differentiation and cytolytic activity.

Authors:  Steven D Hatfield; Keith A Daniels; Carey L O'Donnell; Stephen N Waggoner; Raymond M Welsh
Journal:  Virology       Date:  2018-04-30       Impact factor: 3.616

8.  Interferon-driven deletion of antiviral B cells at the onset of chronic infection.

Authors:  Benedict Fallet; Kerstin Narr; Yusuf I Ertuna; Melissa Remy; Rami Sommerstein; Karen Cornille; Mario Kreutzfeldt; Nicolas Page; Gert Zimmer; Florian Geier; Tobias Straub; Hanspeter Pircher; Kevin Larimore; Philip D Greenberg; Doron Merkler; Daniel D Pinschewer
Journal:  Sci Immunol       Date:  2016-10-21

Review 9.  The role of NK cells in rheumatoid arthritis.

Authors:  Anwar Fathollahi; Leila Nejatbakhsh Samimi; Maassoumeh Akhlaghi; Ahmadreza Jamshidi; Mahdi Mahmoudi; Elham Farhadi
Journal:  Inflamm Res       Date:  2021-09-27       Impact factor: 4.575

Review 10.  Targeting natural killer cells to enhance vaccine responses.

Authors:  Andrew Cox; Hilal Cevik; H Alex Feldman; Laura M Canaday; Nora Lakes; Stephen N Waggoner
Journal:  Trends Pharmacol Sci       Date:  2021-07-23       Impact factor: 17.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.